XRAY

MKT CAP:$2B

DENTSPLY SIRONA Inc.

Market Cap

$2B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$12.17+$0.90 (+7.99%)

Apr 22, 2026

Company Details

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipmen...

CEO

Daniel T. Scavilla

IPO Date

Aug 12, 1987

Website

www.dentsplysirona.com

Key Metrics TTM

Revenue

$3.7B

-5.9% YoY

Net Income

-$1.4B

EPS (Diluted)

-$6.99

Free Cash Flow

$190M

Revenue / Share

$18.53

Gross Margin

50.6%

Operating Margin

-28.4%

Net Margin

-37.8%

FCF Margin

5.1%

P/S

0.6x

P/E

—

Earnings Reports

Q4 2025

May 14, 2026

PENDING

FY 2025

Feb 26, 2026

$3.7B-3.0%EPS -$3.00

Q3 2025

Nov 6, 2025

$904M-4.9%EPS -$2.14

Q2 2025

Aug 7, 2025

$936M-4.9%EPS -$0.23

FY 2024

Feb 27, 2025

$3.8B-4.3%EPS -$4.48

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 20	$1.1B	$571M	$135M
Q1 21	$1.0B	$579M	$150M
Q2 21	$1.1B	$595M	$154M
Q3 21	$1.0B	$569M	$132M
Q4 21	$1.1B	$593M	$154M
Q1 22	$969M	$521M	$97M
Q2 22	$1.0B	$581M	$119M
Q3 22	$947M	$508M	-$1.2B
Q4 22	$983M	$517M	$65M
Q3 23	$947M	$495M	-$236M
Q4 23	$1.0B	$522M	$73M
Q2 24	$984M	$511M	$50M
Q3 24	$951M	$495M	-$462M
Q4 24	$905M	$446M	-$509M
Q2 25	$936M	$490M	-$128M
Q3 25	$904M	$441M	$49M

Valuation

Quarter	P/S	P/E
Q4 20	0.7x	—
Q1 21	0.7x	14.5x
Q2 21	0.6x	6.7x
Q3 21	0.6x	6.1x
Q4 21	0.6x	6.0x
Q1 22	0.6x	6.7x
Q2 22	0.6x	7.2x
Q3 22	0.6x	—
Q4 22	0.6x	—
Q3 23	0.6x	—
Q4 23	0.6x	—
Q2 24	0.6x	—
Q3 24	0.6x	—
Q4 24	0.6x	—
Q2 25	0.6x	—
Q3 25	0.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 20	$264M	$237M
Q1 21	$49M	$19M
Q2 21	$214M	$178M
Q3 21	$172M	$137M
Q4 21	$222M	$181M
Q1 22	$93M	$49M
Q2 22	$173M	$132M
Q3 22	$109M	$77M
Q4 22	$142M	$110M
Q3 23	$134M	$97M
Q4 23	$160M	$120M
Q2 24	$208M	$156M
Q3 24	$141M	$98M
Q4 24	$87M	$36M
Q2 25	$48M	$16M
Q3 25	$79M	$40M

Capital Expenditures

Quarter	CapEx
Q4 20	$27M
Q1 21	$30M
Q2 21	$36M
Q3 21	$35M
Q4 21	$41M
Q1 22	$44M
Q2 22	$41M
Q3 22	$32M
Q4 22	$32M
Q3 23	$37M
Q4 23	$40M
Q2 24	$52M
Q3 24	$43M
Q4 24	$51M
Q2 25	$32M
Q3 25	$39M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 20	-2.6%	-2.9%
Q1 21	+17.4%	-12.3%
Q2 21	+116.3%	+52.6%
Q3 21	+17.8%	+12.0%
Q4 21	+0.5%	-1.4%
Q1 22	-5.6%	-0.5%
Q2 22	-3.7%	-0.4%
Q3 22	-8.9%	+138.4%
Q4 22	-9.7%	-1.7%
Q3 23	-2.3%	+35.7%
Q4 23	-1.1%	+3.9%
Q2 24	+3.9%	-56.9%
Q3 24	-3.3%	+53.9%
Q4 24	-4.4%	+19.5%
Q2 25	-7.5%	+13.3%
Q3 25	-8.1%	-8.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 20	$0	0.0%
Q1 21	$13M	1.3%
Q2 21	$19M	1.8%
Q3 21	$22M	2.1%
Q4 21	-$6M	-0.6%
Q1 22	$11M	1.1%
Q2 22	$0	0.0%
Q3 22	$14M	1.5%
Q4 22	$12M	1.2%
Q3 23	$2M	0.2%
Q4 23	$0	0.0%
Q2 24	$12M	1.2%
Q3 24	$12M	1.3%
Q4 24	$4M	0.4%
Q2 25	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 20	—	—	$421M
Q1 21	$40M	—	$386M
Q2 21	$43M	—	$393M
Q3 21	$39M	—	$395M
Q4 21	$59M	—	$374M
Q1 22	$45M	—	$376M
Q2 22	$45M	—	$410M
Q3 22	$41M	—	$401M
Q4 22	$43M	—	$402M
Q3 23	$46M	$373M	—
Q4 23	$43M	—	$416M
Q2 24	$41M	$401M	—
Q3 24	$40M	$391M	—
Q4 24	$42M	—	$395M
Q2 25	$37M	$343M	—
Q3 25	$37M	—	$355M

Revenue Segments

Quarter	Consumables Segment	Technologies And Equipment
Q1 21	$430M	$597M
Q2 21	$445M	$622M
Q3 21	$440M	$629M
Q4 21	$412M	$676M
Q1 22	$404M	$565M
Q2 22	$428M	$595M
Q3 22	$391M	$556M
Q4 22	$381M	$602M

Revenue by Geography

Quarter	Europe	Other Foreign	United States
Q1 22	$411M	$250M	$308M
Q2 22	$414M	$251M	$358M
Q3 22	$358M	$232M	$357M
Q3 23	$354M	$237M	$356M
Q2 24	$387M	$237M	$360M
Q3 24	$347M	$230M	$374M
Q2 25	$404M	$239M	$293M
Q3 25	$382M	$231M	$291M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$374M	$0	$374M
Q2 22	$362M	$0	$362M
Q3 22	$418M	$0	$418M
Q4 22	$365M	$0	$365M
Q1 23	$318M	$0	$318M
Q2 23	$295M	$0	$295M
Q3 23	$309M	$0	$309M
Q4 23	$334M	$0	$334M
Q1 24	$291M	$0	$291M
Q2 24	$279M	$0	$279M
Q3 24	$296M	$0	$296M
Q4 24	$272M	$0	$272M
Q1 25	$398M	$0	$398M
Q2 25	$359M	$0	$359M
Q3 25	$363M	$0	$363M
Q4 25	$326M	$0	$326M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 20	220M	+0.1%	-1.8%
Q1 21	220M	+0.2%	-0.5%
Q2 21	221M	+0.4%	+0.9%
Q3 21	221M	-0.1%	+0.6%
Q4 21	219M	-0.6%	-0.1%
Q1 22	218M	-0.6%	-1.0%
Q2 22	215M	-1.1%	-2.4%
Q3 22	215M	-0.2%	-2.5%
Q4 22	215M	+0.1%	-1.9%
Q3 23	212M	-1.5%	-2.8%
Q4 23	211M	-0.4%	-2.0%
Q2 24	206M	-2.5%	-4.3%
Q3 24	201M	-2.2%	-6.6%
Q4 24	203M	+1.1%	-4.1%
Q2 25	199M	-1.9%	-5.5%
Q3 25	200M	+0.1%	-3.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 20	$212.2K	5K
Q1 21	$201.2K	5K
Q2 21	$208.2K	5K
Q3 21	$203.9K	5K
Q4 21	$217.6K	5K
Q1 22	$193.8K	5K
Q2 22	$204.6K	5K
Q3 22	$189.4K	5K
Q4 22	$65.5K	15K
Q3 23	$63.1K	15K
Q4 23	$67.5K	15K
Q2 24	$65.6K	15K
Q3 24	$63.4K	15K
Q4 24	$64.6K	14K
Q2 25	$66.9K	14K
Q3 25	$64.6K	14K

Revenue / Employee